Assessing effective and balanced twenty-four-hour blood pressure reduction by treatment: methodological aspects.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA (1999) 5.76

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet (2000) 4.93

Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ (2001) 4.66

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators. Lancet (1997) 3.30

Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension (1989) 3.13

1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72

Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens (1987) 2.21

Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet (1983) 2.18

Arterial stiffness. J Hypertens (1999) 2.16

Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. Am J Physiol Regul Integr Comp Physiol (2001) 2.09

Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation (2001) 2.08

European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06

Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension (1995) 2.04

The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03

How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens (2000) 2.02

Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98

Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93

Prognostic value of 24-hour blood pressure variability. J Hypertens (1993) 1.84

Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens (1998) 1.80

Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension (1987) 1.80

Sympathetic activation in obese normotensive subjects. Hypertension (1995) 1.78

A new approach to analysis of the arterial baroreflex. J Hypertens Suppl (1985) 1.76

Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res (1983) 1.74

Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens (1998) 1.73

Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension (1988) 1.69

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia (2005) 1.69

Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol (1988) 1.64

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation (1998) 1.60

Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension (1998) 1.58

Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56

Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens (2007) 1.55

Broad-band spectral analysis of 24 h continuous finger blood pressure: comparison with intra-arterial recordings. Clin Sci (Lond) (1999) 1.52

Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension (1998) 1.51

[Arterial hypertension and cardiac pathology. Diagnostic and therapeutic guidelines presented by the Joint Commission of the ANMCO-SIC-SIIA. Assoziane Nazionale Medici Cardiologi Ospedalieri. Società Italiana di Cardiologia. Società Italiana dell'Ipertensione Arteriosa]. G Ital Cardiol (1999) 1.50

Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46

Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation (1994) 1.45

Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia (1997) 1.45

Potassium depletion and salt sensitivity in essential hypertension. J Clin Endocrinol Metab (2001) 1.44

Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension. Hypertension (1990) 1.43

Cardiovascular effects of an earthquake: direct evidence by ambulatory blood pressure monitoring. Hypertension (2001) 1.43

Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology (2000) 1.42

Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology (1997) 1.41

Lack of autonomic contributions to tonic nitric oxide-mediated vasodilatation in unanesthetized free-moving rats. J Hypertens (1998) 1.39

Metabolic syndrome and biventricular hypertrophy in essential hypertension. J Hum Hypertens (2008) 1.39

Atrial natriuretic factor and arterial baroreceptor reflexes in unanesthetized rats. Hypertension (1990) 1.37

Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens (2001) 1.36

Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings. Hypertension (1993) 1.34

Ambulatory blood pressure monitoring and organ damage. Hypertension (2000) 1.30

Persistent blood pressure increase induced by heavy smoking. J Hypertens (1992) 1.29

Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension (2000) 1.28

Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording. Hypertension (1993) 1.28

Influence of carotid baroreceptors on vascular responses to carotid chemoreceptor stimulation in the dog. Circ Res (1975) 1.27

Blood Pressure Monitoring. Task force V: White-coat hypertension. Blood Press Monit (1999) 1.26

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia (2009) 1.26

Heart rate as marker of sympathetic activity. J Hypertens (1998) 1.23

Effects of aging on 24-h dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol (1995) 1.23

Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens (2011) 1.23

Interplay among carotid sinus, cardiopulmonary, and carotid body reflexes in dogs. Am J Physiol (1976) 1.22

The variable-pressure neck-chamber method for studying the carotid baroreflex in man. Clin Sci Mol Med (1977) 1.20

Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit (2001) 1.18

Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens (1991) 1.17

Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension (1983) 1.17

Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens (1997) 1.16

Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press Monit (1999) 1.13

Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation (1997) 1.11

The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories. Eur Respir J (2011) 1.11

Closed- versus open-loop assessment of heart rate baroreflex. IEEE Eng Med Biol Mag (2001) 1.11

Finapres tracking of systolic pressure and baroreflex sensitivity improved by waveform filtering. J Hypertens (1996) 1.11

Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? J Hum Hypertens (2009) 1.11

Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group. J Hypertens (2001) 1.10

Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects. J Hypertens (1999) 1.10

Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans. Circulation (1997) 1.10

Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens (1998) 1.08

Effect of isometric hand-grip exercise on the carotid sinus baroreceptor reflex in man. Clin Sci Mol Med (1978) 1.08

Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J (2006) 1.07

Autonomic modulation of the cardiovascular system during sleep. N Engl J Med (1993) 1.07

Role of sinoaortic afferents in modulating BP and pulse-interval spectral characteristics in unanesthetized cats. Am J Physiol (1991) 1.07

Dynamic modulation of baroreflex sensitivity in health and disease. Ann N Y Acad Sci (2001) 1.06

Control of blood pressure by carotid sinus baroreceptors in human beings. Am J Cardiol (1979) 1.06

Local effects of atherosclerotic plaque on arterial distensibility. Hypertension (2001) 1.06